Research Topics
| Johan SvenssonSummaryAffiliation: Lund University Country: Sweden Publications
| Collaborators
|
Detail Information
Publications
Levothyroxine treatment reduces thyroid size in children and adolescents with chronic autoimmune thyroiditisJohan Svensson
Department of Pediatrics, Malmo University Hospital, Lund University, SE 205 02 Malmo, Sweden
J Clin Endocrinol Metab 91:1729-34. 2006..In overtly hypothyroid patients, reductions in thyroid volume have been reported, whereas the effect in subclinically hypothyroid and euthyroid patients is less clear...- Intrauterine exposure to maternal enterovirus infection as a risk factor for development of autoimmune thyroiditis during childhood and adolescenceJohan Svensson
Department of Pediatrics, Malmo University Hospital, Lund University, Malmo, Sweden
Thyroid 14:367-70. 2004.... - Maternal enterovirus infection during pregnancy as a risk factor in offspring diagnosed with type 1 diabetes between 15 and 30 years of ageMaria Elfving
Department of Clinical Sciences, Pediatric Unit, Lund University Hospital, Lund University, 221 85 Lund, Sweden
Exp Diabetes Res 2008:271958. 2008..22-17.6), as compared to boys of IgM-negative mothers (P < .025). These results suggest that gestational enterovirus infections may be related to the risk of offspring developing type 1 diabetes in adolescence and young adulthood... - Thyroid autoantibodies in cord blood sera from children and adolescents with autoimmune thyroiditisJohan Svensson
Department of Pediatrics, Malmo University Hospital, Lund University, Malmo, Sweden
Thyroid 16:79-83. 2006..Whether these autoantibodies have any pathogenetic role in the development of AIT in offspring or if they simply mirror the inheritance of AIT, remains to be investigated... - Interpretation of normative thyroid volumes in children and adolescents: is there a need for a multivariate model?Johan Svensson
Department of Pediatrics, Malmo University Hospital, Lund University, Sweden
Thyroid 14:536-43. 2004..Using these models the difference between the BSA-specific references could be markedly reduced. To interpret thyroid volume accurately we propose the use of a multivariate model using age and BSA as predictors of thyroid volume... - [Androgen insensitivity syndrome]Yvonne Lundberg Giwercman
Molekylärmedicinsk reproduktionsforskning Institutionen för kliniska vetenskaper Lunds Universitet S 20502 Malmö
Tidsskr Nor Laegeforen 128:581-5. 2008..This article discusses the role of androgens in sex differentiation, the structure and function of the androgen receptor, the genetic background to androgen insensitivity as well as clinical aspects... - Immigration and the incidence of Graves' thyrotoxicosis, thyrotoxic multinodular goiter and solitary toxic adenomaMikael Lantz
Department of Endocrinology Pediatrics, Malmo University Hospital, 20502 Malmo, Sweden
Eur J Endocrinol 160:201-6. 2009..The aim was to investigate whether the incidence of Graves' thyrotoxicosis (GD), toxic multinodular goiter (TMNG), and solitary toxic adenoma (STA) has changed in Malmö since 1990 and to study the influence of geographic origin... - Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short statureBerit Kriström
Goteborg Pediatric Growth Research Center, Department of Pediatrics, Institute of Clinical Science, the Sahlgrenska Academy at University of Gothenburg, Goteborg, Sweden
J Clin Endocrinol Metab 94:483-90. 2009..Weight-based GH dosing results in a wide variation in growth response in children with GH deficiency (GHD) or idiopathic short stature (ISS)... - Fracture incidence in GH-deficient patients on complete hormone replacement including GHHelene Holmer
Department of Internal Medicine, Centralsjukhuset, Kristianstad, Sweden
J Bone Miner Res 22:1842-50. 2007..Studying fracture incidence in 832 patients on GH therapy and 2581 matched population controls, we recorded a doubled fracture risk in CO GHD women, but a significantly lower fracture risk in AO GHD men... - Functional analysis of monocarboxylate transporter 8 mutations identified in patients with X-linked psychomotor retardation and elevated serum triiodothyronineJurgen Jansen
Department of Internal Medicine, Erasmus Medical Center, Room Ee502, Dr Molewaterplein 50, Rotterdam, The Netherlands
J Clin Endocrinol Metab 92:2378-81. 2007..Hemizygous mutations have been identified in the X-linked MCT8 gene in boys with severe psychomotor retardation and elevated serum T(3) levels... - Healthcare utilization, quality of life and patient-reported outcomes during two years of GH replacement therapy in GH-deficient adults--comparison between Sweden, The Netherlands and GermanyBernhard Saller
Medical Department, Pfizer GmbH, Karlsruhe, Karlsruhe, Germany
Eur J Endocrinol 154:843-50. 2006..This study set out to determine the change in quality of life (QoL) and healthcare utilization during 2 years of growth hormone (GH) replacement therapy in adults with GH deficiency. Data were compared from three European countries... - Liver-derived IGF-I regulates exploratory activity in old miceJohan Svensson
Research Centre for Endocrinology and Metabolism, Department of Internal Medicine, Sahlgrenska University Hospital, Sweden
Am J Physiol Endocrinol Metab 289:E466-73. 2005..These results indicate that liver-derived IGF-I mediates at least part of the effects of GH on exploratory activity in mice... - Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardationEdith C H Friesema
Department of Internal Medicine, Erasmus MC, Rotterdam, Netherlands
Lancet 364:1435-7. 2004..We suggest that this novel syndrome of X-linked psychomotor retardation is due to a defect in T3 entry into neurons through MCT8, resulting in impaired T3 action and metabolism... - Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumptionJohan Svensson
Research Centre for Endocrinology and Metabolism, Sahlgrenska University Hospital, SE 413 45, Goteborg, Sweden
Growth Horm IGF Res 14:207-15. 2004..The objective was to investigate the effects of 3 years of growth hormone (GH) replacement therapy in GH deficient (GHD) patients in Sweden...